About | Free Trial

Last Update

2016-06-25T00:00:00.000Z

This profile was last updated on . .

Is this you? Claim your profile.

Wrong Neil Berinstein?

Dr. Neil Berinstein L.

Chief Scientific Officer

IRX Therapeutics Inc

Direct Phone: (631) ***-****       

Email: n***@***.com

IRX Therapeutics Inc

140 West 57Th St. Suite 9C

New York, New York 10019

United States

Company Description

IRX Therapeutics develops immune therapies to treat cancer and related diseases. The company's therapies are designed to target and restore the immune system in order to improve a patient's response to next-generation cancer vaccines and novel targeted th... more

Find other employees at this company (27)

Background Information

Employment History

Vice President

CANVAC

Assistant Vice President and Global Program Leader

Sanofi Pasteur Limited

Affiliations

Part of the Executive Steering Committee
Cancer Research Institute

Science Advisory Board
ImmunoVaccine Technologies Inc.

Scientific Advisory Board Member
Molecular Templates Inc

Advisory Boards Member
Phacilitate Limited

Board Member
Canadian Blood and Marrow Transplant Group

Member
Leukemia Research Fund

Post-Doctoral Fellow
Stanford University

Education


Internal Medicine and Medical Oncology
University of Toronto

M.D.
Department of Medicine

MD

University of Manitoba

Medical Doctoral Degree

University of Manitoba

pre-medical degree

University of Manitoba

premedical degree

University of Manitoba

Web References (174 Total References)


Neil L. Berinstein, MD, ...

irxtherapeutics.com [cached]

Neil L. Berinstein, MD, FRCP(C), ABIM

Neil L. Berinstein, MD, FRCP(C), ABIM was appointed Chief Scientific Advisor in January 2010. Prior to joining IRX Therapeutics, Dr. Berinstein served as Assistant Vice President and Global Program Leader at Sanofi Pasteur, where he was in charge of leading the development of Sanofi's cancer vaccines both strategically and operationally. Dr. Berinstein was responsible for interacting with international collaborators and leading researchers who were collaborating with Sanofi Pasteur either at preclinical or clinical levels. He saw to completion several multicenter phase 1 and phase 2 studies in Canada and the US in colorectal and melanoma projects.
Dr. Berinstein currently holds multiple academic and professional positions, including Professor in the Department of Medicine, University of Toronto, and Affiliate Scientist, Biological Sciences at the Odette Cancer Centre of the Sunnybrook Health Sciences Centre, Toronto. He was the Vice President of the Cancer Vaccine Consortium sponsored by the Sabin Institute and more recently is part of the executive steering committee of the Cancer Research Institute (CRI)-sponsored Cancer Vaccine Consortium. He was formerly a member and leader of the scientific review committee of the Leukemia Research Fund.
Dr. Berinstein has been the recipient of numerous grants in his research career and has published 6 book chapters, and over 100 peer-reviewed, invited or review papers to date. He received his premedical degree and Medical Doctorate from the University of Manitoba and further specialty and research training at the University of Toronto and Stanford University.


IRX Therapeutics | Making Cancer Treatments Better

www.irxtherapeutics.com [cached]

Neil L. Berinstein, MD


IRX Therapeutics | Making Cancer Treatments Better

www.irxtherapeutics.com [cached]

Neil L. Berinstein, MD


IRX Therapeutics | Making Cancer Treatments Better

www.irxtherapeutics.com [cached]

Neil L. Berinstein, MD

...
NEIL L. BERINSTEIN, MD was appointed Chief Scientific Advisor in January 2010. Prior to IRX, Dr. Berinstein served as Assistant Vice President and Global Program Leader at sanofi pasteur where he was in charge of leading the development of sanofi’s cancer vaccines both strategically and operationally. Dr. Berinstein was responsible for interacting with international collaborators and leading researchers who were collaborating with sanofi pasteur either at pre-clinical or clinical levels. He saw to completion several multi-center phase I and phase II studies in Canada and the U.S. in colorectal and melanoma projects.
Dr. Berinstein currently holds multiple academic and professional positions, including Professor in the department of medicine, University of Toronto, and Active staff at the Odette Cancer Center of the Sunnybrook Health Science Center. He was the vice-president of the Cancer Vaccine Consortium sponsored by the Sabin Institute and more recently is part of the executive steering committee of the Cancer Research Institute (CRI)-sponsored Cancer Vaccine Consortium. He was formerly a member and leader of the scientific review committee of the Leukemia Research Fund.
Dr. Berinstein is the recipient of numerous grants in his research career and has published 6 book chapters, and over 100 peer-reviewed, invited or review papers to date. He received his pre-medical degree and Medical Doctorate from University of Manitoba and further specialty and research training at the University of Toronto and Stanford University.


IRX Therapeutics | Making Cancer Treatments Better

www.irxtherapeutics.com [cached]

Neil L. Berinstein, MD

Similar Profiles

Other People with this Name

Other people with the name Berinstein

Mariette Berinstein
Rosen Method Institute Canada

Florencia Berinstein
//www.wahc-museum.ca/

Henry Berinstein
Aegis Capital Corp.

Juana Berinstein
Association of Ontario Midwives

Corinne Berinstein
University of Toronto

Browse ZoomInfo's Business Contact Directory by City

Browse ZoomInfo's
Business People Directory

Browse ZoomInfo's
Advanced Company Directory